Hematologic Malignancy
225
64
79
74
Key Insights
Highlights
Success Rate
80% trial completion
Published Results
33 trials with published results (15%)
Research Maturity
74 completed trials (33% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
8.4%
19 terminated out of 225 trials
79.6%
-6.9% vs benchmark
5%
11 trials in Phase 3/4
45%
33 of 74 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 74 completed trials
Clinical Trials (225)
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Allergy Delabeling in Antibiotic Stewardship - Intervention
CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy
ONC-MM-2407: The Effect of Virtual Reality Headsets on Pain and Anxiety in the Peri and Post Bone Marrow Biopsy Period
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials
Long-Term Follow-up Study
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies
Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Expressive Writing Program Among Young Adults With Blood Cancer
Assessing DCog Short for Neurotoxicity in CAR-T
A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors